节点文献

国外罕见病管理制度对中国的启示

Enlightment of foreign management system of rare diseases to China

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 王煜卢建华赵太宏肖雨龙

【Author】 WANG Yu;LU Jian-hua;ZHAO Tai-hong;XIAO Yu-long;Dept.of Medicine,the First Hospital of Nanjing,Nanjing Medical University;School of Health Policy & Management,Nanjing Medical University;

【机构】 南京医科大学附属南京医院(南京市第一医院)医务处南京医科大学医政学院

【摘要】 通过对部分国家和地区罕见病法案的分析,探讨罕见病管理的国际经验。中国应尽快推进罕见病立法,明确罕见病界定标准,加强转化医学研究,提高罕见病诊断治疗水平。应加强政策导向作用,完善激励措施,加强多部门协作,建立健全罕见病医疗保障体系,建立与中国国情相适应的罕见病管理体系。

【Abstract】 Through analyses of rare diseases management of several countries and regions,successful practice has been discussed. Legislation of rare diseases should be activated as soon as possible to release specific standard of rare diseases. Accelerating development of translational medicine is a feasible approach to improve the level of diagnosis and treatment of rare diseases. Strengthening the orientation of management policy should be put into a more significant position to promote incentives of stakeholder in this area. Both enhancing the joint collaboration of different departments and perfecting medical insurance system could be forceful accelerants to create and optimize the management system of rare diseases in China.

【关键词】 罕见病罕用药立法界定标准
【Key words】 rare diseasesorphan druglegislationdefinition standards
【基金】 江苏省科技发展计划(软科学研究)(BR2012052);江苏现代医院管理研究中心研究基金(JSY-3-2015-042);江苏现代医院管理研究中心研究基金(JSY-2-2016-061)
  • 【文献出处】 基础医学与临床 ,Basic & Clinical Medicine , 编辑部邮箱 ,2017年02期
  • 【分类号】R95
  • 【被引频次】7
  • 【下载频次】450
节点文献中: 

本文链接的文献网络图示:

本文的引文网络